tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alex Schwartz, 12 are a BUY (85.71%), 2 are a HOLD (14.29%).
Analyst Alex Schwartz, carries an average stock price target met ratio of 40% that have a potential upside of 16.57% achieved within 421 days. Previously, Alex Schwartz worked at STIFEL.
Alex Schwartz’s has documented 28 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on PBYI, Puma Biotechnology at 10-May-2018.
Analyst best performing recommendations are on MNTA (MOMENTA PHARMACEUTICALS).
The best stock recommendation documented was for MNTA (MOMENTA PHARMACEUTICALS) at 1/5/2018. The price target of $15 was fulfilled within 4 days with a profit of $2.55 (14.53%) receiving and performance score of 36.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Dec-2021
$5
4 months 22 days ago
(04-May-2026)
1/14 (7.14%)
$2.09 (71.82%)
205
Buy Since 11-Mar-2022
$3.16
$-0.02 (-0.63%)
$16
4 months 25 days ago
(01-May-2026)
1/8 (12.5%)
$0.05 (1.61%)
46
Buy Since 11-Nov-2015
$5
$1.82 (57.23%)
$4
6 months 13 days ago
(13-Mar-2026)
4/16 (25%)
$2.56 (104.92%)
358
Buy Since 25-Nov-2025
$9
$5.82 (183.02%)
10 months 1 days ago
(25-Nov-2025)
0/1 (0%)
$5.31 (143.90%)
Buy Since 17-Dec-2024
$8
11 months 9 days ago
(17-Oct-2025)
0/1 (0%)
$5.54 (225.20%)
